BridgeBio Oncology Therapeutics, Inc.

Nasdaq:BBOT

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA

Financials

8 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/5/26	→
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/1/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	3/11/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
↓

Earnings Releases (8-K)

2 shown

Filed	Period
3/5/26	Q1 FY2026	→
11/12/25	Q4 FY2025	→

News (8-K)

10 shown

Filed	Type	Description
1/7/26	Other	Other Events	→
8/13/25	Acquisition	Entry into a Material Definitive Agreement	→
8/6/25	Reg FD	Regulation FD Disclosure	→
8/4/25	Vote	Submission of Matters to a Vote of Security Holders	→
7/11/25	Reg FD	Regulation FD Disclosure	→
3/3/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

17 shown

Filed	Form	Description
3/6/26	424B3	424B3	→
1/7/26	424B3	424B3	→
1/7/26	424B3	424B3	→
1/2/26	S-8	S-8	→
10/10/25	S-8	S-8	→
9/10/25	424B3	424B3	→
↓

Filing History(128 filings)

TypeDateAccessionPeriodSize

424B3

Mar 6, 2026

0001193125-26-094856424B3

—

5.1 MB

10-K

Mar 5, 2026

0001193125-26-09411210-K

Dec 31, 2025

15.4 MB

8-K

Mar 5, 2026

0001193125-26-0939978-K

Mar 5, 2026

766.5 KB

424B3

Jan 7, 2026

0001193125-26-005435424B3

—

67.1 KB

424B3

Jan 7, 2026

0001193125-26-005428424B3

—

1.3 MB

8-K

Jan 7, 2026

0001193125-26-0054258-K

Jan 7, 2026

192.5 KB

Jan 5, 2026

0001193125-26-0030274

Jan 1, 2026

5.5 KB

S-8

Jan 2, 2026

0001193125-26-000904S-8

—

185.9 KB

Dec 12, 2025

0001193125-25-3179624

Dec 10, 2025

5.8 KB

SCHEDULE 13G/A

Nov 14, 2025

0001104659-25-112512

—

18.1 KB

SCHEDULE 13G/A

Nov 13, 2025

0000902664-25-004881

—

12.3 KB

10-Q

Nov 12, 2025

0001193125-25-27783410-Q

Sep 30, 2025

10.3 MB

8-K

Nov 12, 2025

0001193125-25-2776018-K

Nov 12, 2025

206.5 KB

Oct 16, 2025

0001193125-25-2416344

Oct 10, 2025

8.0 KB

S-8

Oct 10, 2025

0001193125-25-237057S-8

—

359.5 KB

Oct 6, 2025

0001193125-25-2319174

Oct 2, 2025

5.4 KB

EFFECT

Sep 10, 2025

9999999995-25-002915

—

1.8 KB

424B3

Sep 10, 2025

0001193125-25-200153424B3

—

8.7 MB

CORRESP

Sep 8, 2025

0001193125-25-198323

—

6.5 KB

UPLOAD

Sep 3, 2025

0000000000-25-009499

—

39.3 KB

SCHEDULE 13G

Sep 3, 2025

0002013681-25-000001

—

11.3 KB

S-1

Aug 29, 2025

0001193125-25-192760S-1

—

19.0 MB

Aug 28, 2025

0000950170-25-1120204

Aug 26, 2025

5.9 KB

Aug 28, 2025

0000950170-25-1120164

Aug 26, 2025

5.9 KB

Aug 28, 2025

0000950170-25-1120084

Aug 26, 2025

5.9 KB

25 filings shown

BridgeBio Oncology Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(128 filings)

Ownership

Other Filings

Filed	Form	Description
1/5/26	4	4	→
12/12/25	4	4	→
10/16/25	4	4	→
10/6/25	4	4	→
8/28/25	4	4	→
8/28/25	4	4	→
↓

Filed	Form	Description
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/13/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
9/10/25	EFFECT	EFFECT	→
9/3/25	SCHEDULE 13G	SCHEDULE 13G	→
8/19/25	EFFECT	EFFECT	→
8/18/25	SCHEDULE 13G	SCHEDULE 13G	→
↓